The firm manages the most number of L&I products in the SAR.
Tag: CSOP
E Fund to terminate L&I products in Hong Kong
Competitor CSOP AM manages the same kind of products, which have become the largest L&I funds in the SAR.
Working From Home: BNPP AM and CSOP AM
Caroline Yu Maurer, head of Greater China equities, BNPP Asset Management and Kerry Zhang, fixed income portfolio manager at CSOP Asset Management, explain how they have been working from home during the coronavirus outbreak.
CSOP opens Singapore office
The China asset manager plans to use the city-state financial hub to grow its business in Southeast Asia.
China AMC to debut 2x inverse product
Separately, one of CSOP Asset Management’s recently launched (-2x) inverse products has become the second largest L&I ETF in Hong Kong.
China Top Trumps – China equities
This week FSA presents a quick comparison of two China equity products: the Aberdeen Standard SICAV I China A Share Equity Fund and the CSOP FTSE China A50 ETF Fund.
Few China equity funds outperform
FSA looks at China equity fund performance over a three-year period to the end of June.
The FSA Spy market buzz – 14 June 2019
What a week for Hong Kong; a move at CBH Asia; Capital Group adds; moves at JP Morgan AM; passive product trouble?; a humbled star manager; brands in various countries; advertising from Jupiter and much more.
CSOP debuts ‘global quant mixed-asset’ index
The firm’s private fund, which includes proprietary money from CSOP and UBS, is benchmarked against the index.
The FSA Spy market buzz – 08 June 2018
A change at M&G; Naming fund companies; Emerging markets and timing; Sage advice from the 1990s; Singapore with Trump and Kim; advertising from Pictet, Vanguard and CSOP and much more.
